PMC:7377212 / 717-969 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T15","span":{"begin":2,"end":15},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T16","span":{"begin":50,"end":56},"obj":"NCBITaxon:4751"},{"id":"T17","span":{"begin":85,"end":93},"obj":"SP_7"},{"id":"T18","span":{"begin":105,"end":114},"obj":"UBERON:0002048"},{"id":"T19","span":{"begin":173,"end":181},"obj":"SP_7"},{"id":"T20","span":{"begin":193,"end":202},"obj":"UBERON:0002048"},{"id":"T9877","span":{"begin":2,"end":15},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T12804","span":{"begin":50,"end":56},"obj":"NCBITaxon:4751"},{"id":"T73228","span":{"begin":85,"end":93},"obj":"SP_7"},{"id":"T60783","span":{"begin":105,"end":114},"obj":"UBERON:0002048"},{"id":"T68907","span":{"begin":173,"end":181},"obj":"SP_7"},{"id":"T56206","span":{"begin":193,"end":202},"obj":"UBERON:0002048"}],"text":"d antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly repor"}

{"project":"LitCovid-PubTator","denotations":[{"id":"37","span":{"begin":173,"end":181},"obj":"Disease"},{"id":"38","span":{"begin":193,"end":216},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:C000657245"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:D055732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly repor"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":60,"end":69},"obj":"Disease"},{"id":"T17","span":{"begin":85,"end":93},"obj":"Disease"},{"id":"T18","span":{"begin":115,"end":128},"obj":"Disease"},{"id":"T19","span":{"begin":130,"end":134},"obj":"Disease"},{"id":"T20","span":{"begin":173,"end":181},"obj":"Disease"},{"id":"T21","span":{"begin":203,"end":216},"obj":"Disease"},{"id":"T22","span":{"begin":218,"end":222},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"d antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly repor"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":2,"end":15},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"d antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly repor"}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":29,"end":162},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly repor"}